Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptide

Journal of Bioscience and Bioengineering

Volumn 116, Issue 5, 2013, Pages 634-637

  Kawamura, Eriko ^a   Yamada, Yuma ^a   Yasuzaki, Yukari ^a   Hyodo, Mamoru ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

MITO Porter; Mitochondria; Mitochondrial drug delivery; Mitochondrial targeting signal peptide (MTS); Nanocarriers; Nanotechnology

Indexed keywords

CELLULAR UPTAKE; MITO-PORTER; NANO-CARRIERS; SIGNAL PEPTIDE;

DRUG DELIVERY; NANOTECHNOLOGY;

MITOCHONDRIA;

MITOCHONDRIAL PROTEIN; NANOCARRIER; SIGNAL PEPTIDE;

ACTIN FILAMENT; ARTICLE; CELL DENSITY; CELL MIGRATION; CYTOSKELETON; ENDOPLASMIC RETICULUM; ENDOSOME; FLOW CYTOMETRY; GOLGI COMPLEX; LIPID COMPOSITION; MICROTUBULE; MITOCHONDRIAL TARGETING SIGNAL;

MITO-PORTER; MITOCHONDRIA; MITOCHONDRIAL DRUG DELIVERY; MITOCHONDRIAL TARGETING SIGNAL PEPTIDE (MTS); NANOCARRIERS; NANOTECHNOLOGY;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; INTRACELLULAR SPACE; MITOCHONDRIA; NANOMEDICINE; NANOSTRUCTURES; PROTEIN SORTING SIGNALS; SUBSTRATE SPECIFICITY;

EID: 84885381042     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2013.05.001     Document Type: Article

References (20)

1. Szewczyk A., Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 2002, 54:101-127.
2. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
3. Reeve A.K., Krishnan K.J., Turnbull D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:21-29.
4. Schapira A.H. Mitochondrial disease. Lancet 2006, 368:70-82.
5. Zhang E., Zhang C., Su Y., Cheng T., Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov. Today 2011, 16:140-146.
6. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv. Drug Deliv. Rev. 2008, 60:1439-1462.
7. Mukhopadhyay A., Weiner H. Delivery of drugs and macromolecules to mitochondria. Adv. Drug Deliv. Rev. 2007, 59:729-738.
8. Schatz G. The protein import system of mitochondria. J.Biol. Chem. 1996, 271:31763-31766.
9. Vestweber D., Schatz G. DNA-protein conjugates can enter mitochondria via the protein import pathway. Nature 1989, 338:170-172.
10. Rubio M.A., Rinehart J.J., Krett B., Duvezin-Caubet S., Reichert A.S., Soll D., Alfonzo J.D. Mammalian mitochondria have the innate ability to import tRNAs by a mechanism distinct from protein import. Proc. Natl. Acad. Sci. USA 2008, 105:9186-9191.
11. Wang G., Chen H.W., Oktay Y., Zhang J., Allen E.L., Smith G.M., Fan K.C., Hong J.S., French S.W., McCaffery J.M., other 3 authors PNPASE regulates RNA import into mitochondria. Cell 2010, 142:456-467.
12. Yamada Y., Harashima H. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier. Mitochondrion 2013, 13:526-532.
13. Yamada Y., Furukawa R., Yasuzaki Y., Harashima H. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol. Ther. 2011, 19:1449-1456.
14. Yamada Y., Akita H., Harashima H. Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process. Methods Enzymol. 2012, 509:301-326.
15. Yamada Y., Harashima H. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter. Biomaterials 2012, 33:1589-1595.
16. Khalil I.A., Kogure K., Futaki S., Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J.Biol. Chem. 2006, 281:3544-3551.
17. Akita H., Kudo A., Minoura A., Yamaguti M., Khalil I.A., Moriguchi R., Masuda T., Danev R., Nagayama K., Kogure K., Harashima H. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials 2009, 30:2940-2949.
18. El-Sayed A., Khalil I.A., Kogure K., Futaki S., Harashima H. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J.Biol. Chem. 2008, 283:23450-23461.
19. Yamada Y., Akita H., Kamiya H., Kogure K., Yamamoto T., Shinohara Y., Yamashita K., Kobayashi H., Kikuchi H., Harashima H. MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim. Biophys. Acta 2008, 1778:423-432.
20. Yamada Y., Kawamura E., Harashima H. Mitochondrial-targeted DNA delivery using a DF-MITO-Porter, an innovative nano carrier with cytoplasmic and mitochondrial fusogenic envelopes. J.Nanopart. Res. 2012, 14:1-15.